CIK 0001124105 · Accelerated filer<br>Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562020050
- Phone
- (858) 284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-03 | Ma Songjiang President | Sale 10b5-1 | −833 | $11.85 | $10K | 2,918,467 |
| 2025-01-03 | Ma Songjiang President | Sale 10b5-1 | −1,167 | $11.03 | $13K | 2,919,300 |
| 2025-01-02 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $12.40 | $25K | 2,920,467 |
| 2024-12-31 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $12.30 | $25K | 2,922,467 |
| 2024-12-30 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $12.50 | $25K | 2,924,467 |
| 2024-12-27 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $12.58 | $25K | 2,926,467 |
| 2024-12-26 | Ma Songjiang President | Sale 10b5-1 | −1,644 | $12.62 | $21K | 2,928,823 |
| 2024-12-26 | Ma Songjiang President | Sale 10b5-1 | −356 | $13.05 | $5K | 2,928,467 |
| 2024-12-24 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $11.93 | $24K | 2,930,467 |
| 2024-12-23 | Ma Songjiang President | Sale 10b5-1 | −1,704 | $12.24 | $21K | 2,932,763 |
| 2024-12-23 | Ma Songjiang President | Sale 10b5-1 | −296 | $12.44 | $4K | 2,932,467 |
| 2024-12-20 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.90 | $22K | 2,934,467 |
| 2024-12-19 | Ma Songjiang President | Sale 10b5-1 | −2,000 | $10.82 | $22K | 2,936,467 |
| 2024-12-18 | Ma Songjiang President | Sale 10b5-1 | −1,571 | $11.17 | $18K | 2,938,896 |
| 2024-12-18 | Ma Songjiang President | Sale 10b5-1 | −429 | $12.11 | $5K | 2,938,467 |
| 2024-12-17 | Ma Songjiang President | Sale 10b5-1 | −1,212 | $10.94 | $13K | 2,941,255 |
| 2024-12-17 | Ma Songjiang President | Sale 10b5-1 | −788 | $11.23 | $9K | 2,940,467 |
| 2024-08-14 | Nussbaum Rodney L Director | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2024-08-14 | Parry Renate Director | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 | ||
| 2024-08-14 | Epstein David M. Director | Grant or award · Stock Option (Right to Buy) | +52,000 | 52,000 |
Page 9 of 11 · 215 trades